Month: October 2025
Meet the CSEP Team Series: Dr Arianna Gentilini
Meet Dr Arianna Gentilini, Research Associate in the Economics and Public Policy Department, Lord Sainsbury Fellow in Biopharma Productivity.
Meet the CSEP Team Series: Dr Joachim Taiber
Meet the CSEP Team Series: Dr Nigel Steward
Meet Dr Nigel Steward, Professor of Practice and the Director of the Centre for Sectoral Economic Performance.
Is the UK biopharma sector at risk of sleepwalking into decline?
Author: James Barlow
For years, the UK has traded on its reputation as a “life sciences powerhouse.” This narrative isn’t entirely false: we have world-class universities, our basic science is strong, and the NHS provides a unique testbed for clinical research. Yet behind the rhetoric, the biopharma sector is facing real and immediate challenges.
UK HealthTech Roadshow Unites Industry, Academia, and Government to Shape MedTech’s Future
The government has placed growth at the heart of its mission and in June of this year published its Industrial Strategy. One important issue raised by the Industrial Strategy is the need to better understand the relationship between national sector strategies and the regional areas where firms are located.
The high-level Sector Plans identified the most important city regions and clusters for the given sector. In addition, regional authorities are developing ambitious Local Growth Plans which are supposed to dovetail with the Industrial Strategy Sector Plans. These local plans need to tackle the critical issues that are constraining growth across sectors including poor transport connections, skills shortages and housing.